The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Temperature-Responsive Multilayer Films of Micelle-Based Composites for Controlled Release of a Third-Generation EGFR Inhibitor
Abstract
Lung cancer is a complicated long-term disease, which is extremely difficult to cure. A traditional single drug delivery system cannot achieve desired long-term controlled release of therapeutic compounds. Our previous studies have found that temperature-responsive micelles demonstrated high loading efficiency and a long-term controlled release rate, which allows them to be an efficient drug delivery system. We utilized temperature-responsive micelles and hyaluronic acid biopolymers to create a sandwich-like membrane based on hydrogen bonding by layer-by-layer (LBL) self-assembly technology. The multilayer films efficiently absorbed osimertinib—the third-generation inhibitor for nonsmall cell lung cancer (NSCLC) treatment. The release profile of osimertinib from the films is controlled by environmental stimuli. Block copolymer micelles with a poly( N -isopropylacrylamide) (PNIPAM) core were deposited into the multilayer films to introduce temperature sensitivity to the composite thin films. By the above approach, we built a drug carrier for the delivery of an anticancer drug, which potentially demonstrates good loading capacity, high morphology stability, and a controllable drug release mode. We investigated the films’ responsive behavior to temperature and ionic strength and loading capacity of the composite membrane and explored the influence of each component on the response of the drug release profile to environmental triggers. The films retained their morphology integrity after several temperature-triggered swelling/deswelling cycles based on atomic force microscopy and ellipsometry measurements. The mechanism of the intermolecular interaction and molecular motions in the system was studied to elucidate the relationship between structure and delivering efficiency of the system. Development of the LBL films can provide ideas for the modification of traditional drug delivery materials. More importantly, nanoparticle layer-by-layer self-assembly and micro/nanoscale structure manipulation for controlled release of therapeutic compounds are also beneficial to future design and development of innovative functional materials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites
Decher, G. (1997) · Science · doi:10.1126/science.277.5330.1232 · Cited by 10,054
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
Soria, J.-C., Ohe, Y., Vansteenkiste, J., Reungwetwattana, T., Chewaskulyong, B., Lee, K. H., Dechaphunkul, A., Imamura, F., Nogami, N., Kurata, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713137 · Cited by 5,508
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
Mok, T. S., Wu, Y.-L., Ahn, M.-J., Garassino, M. C., Kim, H. R., Ramalingam, S. S., Shepherd, F. A., He, Y., Akamatsu, H., Theelen, W. S. M. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612674 · Cited by 3,379
Cross, D. A. E., Ashton, S. E., Ghiorghiu, S., Eberlein, C., Nebhan, C. A., Spitzler, P. J., Orme, J. P., Finlay, M. R. V., Ward, R. A., Mellor, M. J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0337 · Cited by 2,246
Technology-driven layer-by-layer assembly of nanofilms
Richardson, J. J., Björnmalm, M., & Caruso, F. (2015) · Science · doi:10.1126/science.aaa2491 · Cited by 1,641
Lu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
Oxnard, G. R., Thress, K. S., Alden, R. S., Lawrance, R., Paweletz, C. P., Cantarini, M., Yang, J. C.-H., Barrett, J. C., & Jänne, P. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.7162 · Cited by 850
Goss, G., Tsai, C.-M., Shepherd, F. A., Bazhenova, L., Lee, J. S., Chang, G.-C., Crino, L., Satouchi, M., Chu, Q., Hida, T., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30508-3 · Cited by 645
Qi, H., Teng, M., Liu, M., Liu, S., Li, J., Yu, H., Teng, C., Huang, Z., Liu, H., Shao, Q., et al. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.12.047 · Cited by 640
Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer
Ramalingam, S. S., Yang, J. C.-H., Lee, C. K., Kurata, T., Kim, D.-W., John, T., Nogami, N., Ohe, Y., Mann, H., Rukazenkov, Y., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.7576 · Cited by 547
Cited by
Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications
Mondal, J., Pillarisetti, S., Junnuthula, V., Saha, M., Hwang, S. R., Park, I.-K., & Lee, Y.-K. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.027 · Cited by 416
Metadata
- Authors
- Xu, L., Wang, H., Chu, Z., Cai, L., Shi, H., Zhu, C., Pan, D., Pan, J., Fei, X., & Lei, Y.
- Venue
- ACS Applied Polymer Materials
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-01-17
- Volume
- 2
- Issue
- 2
- Pages
- 741-750
- ISSN
- 2637-6105 (ISSN-L)
- OpenAlex
- W2998932657
- Cited by
- 340
- References
- 46
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Temperature-Responsive Multilayer Films of Micelle-Based Composites for Controlled Release of a Third-Generation EGFR Inhibitor. https://app.cochat.ai/papers/10.1021/acsapm.9b01051
- The paper
- Xu, L., Wang, H., Chu, Z., Cai, L., Shi, H., Zhu, C., Pan, D., Pan, J., Fei, X., & Lei, Y. (2020). Temperature-Responsive Multilayer Films of Micelle-Based Composites for Controlled Release of a Third-Generation EGFR Inhibitor. ACS Applied Polymer Materials. https://doi.org/10.1021/acsapm.9b01051
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.